|
1.
|
Brunagel G, Vietmeier BN, Bauer AJ, Schoen
RE and Getzenberg RH: Identification of nuclear matrix protein
alterations associated with human colon cancer. Cancer Res.
62:2437–2442. 2002.PubMed/NCBI
|
|
2.
|
Fey MF: Adjuvant therapy for colon cancer.
Schweiz Med Wochenschr. 130:1760–1765. 2000.(In German).
|
|
3.
|
Cragg GM, Grothaus PG and Newman DJ:
Impact of natural products on developing new anti-cancer agents.
Chem Rev. 109:3012–3043. 2009. View Article : Google Scholar
|
|
4.
|
Mishra BB and Tiwari VK: Natural products:
an evolving role in future drug discovery. Eur J Med Chem.
46:4769–4807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zou DM, Brewer M, Garcia F, et al: Cactus
pear: a natural product in cancer chemoprevention. Nutr J.
4:252005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Konkimalla VB and Efferth T: Anti-cancer
natural product library from traditional Chinese medicine. Comb
Chem High Throughput Screen. 11:7–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Khan N, Afaq F and Mukhtar H: Cancer
chemoprevention through dietary antioxidants: progress and promise.
Antioxid Redox Signal. 10:475–510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Korkina LG, De Luca C, Kostyuk VA and
Pastore S: Plant polyphenols and tumors: from mechanisms to
therapies, prevention, and protection against toxicity of
anti-cancer treatments. Curr Med Chem. 16:3943–3965. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Das S, Santani DD and Dhalla NS:
Experimental evidence for the cardioprotective effects of red wine.
Exp Clin Cardiol. 12:5–10. 2007.
|
|
10.
|
Jang M, Cai L, Udeani GO, et al: Cancer
chemopreventive activity of resveratrol, a natural product derived
from grapes. Science. 275:218–220. 1997. View Article : Google Scholar
|
|
11.
|
Gehm BD, McAndrews JM, Chien PY and
Jameson JL: Resveratrol, a polyphenolic compound found in grapes
and wine, is an agonist for the estrogen receptor. Proc Natl Acad
Sci USA. 94:14138–14143. 1997. View Article : Google Scholar
|
|
12.
|
Bhat KPL, Kosmeder JW II and Pezzuto JM:
Biological effects of resveratrol. Antioxid Redox Signal.
3:1041–1064. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gulvady AA, Ciolino HP, Cabrera RM and
Jolly CA: Resveratrol inhibits the deleterious effects of
diet-induced obesity on thymic function. J Nutr Biochem.
24:1625–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Fang JY, Li ZH, Li Q, Huang WS, Kang L and
Wang JP: Resveratrol affects protein kinase C activity and promotes
apoptosis in human colon carcinoma cells. Asian Pac J Cancer Prev.
13:6017–6022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lu R and Serrero G: Resveratrol, a natural
product derived from grape, exhibits antiestrogenic activity and
inhibits the growth of human breast cancer cells. J Cell Physiol.
179:297–304. 1999. View Article : Google Scholar
|
|
16.
|
Sheth S, Jajoo S, Kaur T, et al:
Resveratrol reduces prostate cancer growth and metastasis by
inhibiting the Akt/MicroRNA-21 pathway. PLoS One. 7:e516552012.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Fouad M, Agha A, Merzabani MA and Shouman
S: Resveratrol inhibits proliferation, angiogenesis and induces
apoptosis in colon cancer cells: Calorie restriction is the force
to the cytotoxicity. Hum Exp Toxicol. 32:1067–1080. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yang HL, Chen WQ, Cao X, et al: Caveolin-1
enhances resveratrol-mediated cytotoxicity and transport in a
hepatocellular carcinoma model. J Transl Med. 7:222009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Miura D, Miura Y and Yagasaki K:
Hypolipidemic action of dietary resveratrol, a phytoalexin in
grapes and red wine, in hepatoma-bearing rats. Life Sci.
73:1393–1400. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Liu HS, Pan CE, Yang W and Liu XM:
Antitumor and immunomodulatory activity of resveratrol on
experimentally implanted tumor of H22 in Balb/c mice. World J
Gastroenterol. 9:1474–1476. 2003.PubMed/NCBI
|
|
21.
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and Gonzalez-Baron M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004.PubMed/NCBI
|
|
22.
|
Mahimainathan L and Choudhury GG:
Inactivation of platelet-derived growth factor receptor by the
tumor suppressor PTEN provides a novel mechanism of action of the
phosphatase. J Biol Chem. 279:15258–15268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Takeda K, Kanekura T and Kanzaki T:
Negative feedback regulation of phosphatidylinositol 3-kinase/Akt
pathway by over-expressed cyclooxygenase-2 in human epidermal
cancer cells. J Dermatol. 31:516–523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Chalhoub N and Baker SJ: PTEN and the
PI3-kinase pathway in cancer. Annu Rev Pathol. 4:127–150. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Waniczek D, Snietura M, Mlynarczyk-Liszka
J, et al: PTEN expression profiles in colorectal adenocarcinoma and
its precancerous lesions. Pol J Pathol. 64:15–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Franke TF, Kaplan DR, Cantley LC and Toker
A: Direct regulation of the Akt proto-oncogene product by
phosphatidylinositol-3,4-bisphosphate. Science. 275:665–668. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Zhang W, Zhang H, Wang N, et al:
Modulation of β-catenin signaling by the inhibitors of MAP kinase,
tyrosine kinase, and PI3-kinase pathways. Int J Med Sci.
10:1888–1898. 2013.
|
|
28.
|
Robertson BW and Chellaiah MA: Osteopontin
induces beta-catenin signaling through activation of Akt in
prostate cancer cells. Exp Cell Res. 316:1–11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
He BC, Chen L, Zuo GW, et al: Synergistic
antitumor effect of the activated PPARgamma and retinoid receptors
on human osteosarcoma. Clin Cancer Res. 16:2235–2245. 2010.
View Article : Google Scholar
|
|
30.
|
Stepanovic S, Vukovic D, Dakic I, Savic B
and Svabic-Vlahovic M: A modified microtiter-plate test for
quantification of staphylococcal biofilm formation. J Microbiol
Methods. 40:175–179. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
He TC, Zhou S, da Costa LT, Yu J, Kinzler
KW and Vogelstein B: A simplified system for generating recombinant
adenoviruses. Proc Natl Acad Sci USA. 95:2509–2514. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
|
33.
|
Pal I and Mandal M: PI3K and Akt as
molecular targets for cancer therapy: current clinical outcomes.
Acta Pharmacol Sin. 33:1441–1458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lin MS, Huang JX, Chen WC, et al:
Expression of PPARgamma and PTEN in human colorectal cancer: An
immunohistochemical study using tissue microarray methodology.
Oncol Lett. 2:1219–1224. 2011.PubMed/NCBI
|
|
35.
|
Garcia JM, Silva JM, Dominguez G, et al:
Allelic loss of the PTEN region (10q23) in breast carcinomas of
poor pathophenotype. Breast Cancer Res Treat. 57:237–243. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Aggarwal S and Chu E: Current therapies
for advanced colorectal cancer. Oncology. 19:589–595.
2005.PubMed/NCBI
|
|
37.
|
Athar M, Back JH, Tang X, et al:
Resveratrol: a review of preclinical studies for human cancer
prevention. Toxicol Appl Pharmacol. 224:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Boocock DJ, Faust GE, Patel KR, et al:
Phase I dose escalation pharmacokinetic study in healthy volunteers
of resveratrol, a potential cancer chemopreventive agent. Cancer
Epidemiol Biomarkers Prev. 16:1246–1252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Vanamala J, Reddivari L, Radhakrishnan S
and Tarver C: Resveratrol suppresses IGF-1 induced human colon
cancer cell proliferation and elevates apoptosis via suppression of
IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer.
10:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Gweon EJ and Kim SJ: Resveratrol induces
MMP-9 and cell migration via the p38 kinase and PI-3K pathways in
HT1080 human fibrosarcoma cells. Oncol Rep. 29:826–834.
2013.PubMed/NCBI
|
|
41.
|
Hsu CP, Kao TY, Chang WL, Nieh S, Wang HL
and Chung YC: Clinical significance of tumor suppressor PTEN in
colorectal carcinoma. Eur J Surg Oncol. 37:140–147. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
He BC, Gao JL, Luo X, et al: Ginsenoside
Rg3 inhibits colorectal tumor growth through the down-regulation of
Wnt/β-catenin signaling. Int J Oncol. 38:437–445. 2011.PubMed/NCBI
|
